Renseignements en français

Google Translate Disclaimer

A number of pages on the Government of Saskatchewan's website have been professionally translated in French. These translations are identified by a yellow box in the right or left rail that resembles the link below. The home page for French-language content on this site can be found at:

Renseignements en Français

Where an official translation is not available, Google™ Translate can be used. Google™ Translate is a free online language translation service that can translate text and web pages into different languages. Translations are made available to increase access to Government of Saskatchewan content for populations whose first language is not English.

Software-based translations do not approach the fluency of a native speaker or possess the skill of a professional translator. The translation should not be considered exact, and may include incorrect or offensive language. The Government of Saskatchewan does not warrant the accuracy, reliability or timeliness of any information translated by this system. Some files or items cannot be translated, including graphs, photos and other file formats such as portable document formats (PDFs).

Any person or entities that rely on information obtained from the system does so at his or her own risk. Government of Saskatchewan is not responsible for any damage or issues that may possibly result from using translated website content. If you have any questions about Google™ Translate, please visit: Google™ Translate FAQs.

Vaccine Delivery Phases

Saskatchewan's COVID-19 Vaccine Delivery Plan is designed to save lives and stop the spread of COVID-19. The information on this page is updated frequently and is subject to change based on vaccine availability and the latest COVID-19 data.

Download: COVID-19 Immunization Delivery Plan - Updated October 22, 2021

Top

1. Fully Vaccinated Requirements, Additional Dose Recommendation

Currently, all residents age five years and older are eligible to be vaccinated against COVID-19 in Saskatchewan.

Health Canada has approved one- and two-dose COVID-19 vaccines for use in Canada.

For single-dose vaccinations (Janssen), you are fully vaccinated 14 days after your immunization.

For two-dose vaccinations (Pfizer BioNTech, AstraZeneca, Moderna, Novavax), you are fully vaccinated 14 days following your second dose.

Additional doses are strongly recommended for optimal protection against current COVID-19 variants.

  • All residents 12 years an older are eligible to receive a third dose (first booster) four months after their second dose.
  • All residents 50 years and older are eligible to receive a fourth dose (second booster) four months after their last dose.

If you have designated medical conditions affecting your immune system (see table below), you are eligible to receive your fourth dose three months following your third dose.

Top

2. Third and Fourth Doses

All individuals 12+ are eligible for a third dose at this time, and all residents 50+ are eligible to receive a fourth dose.

Population Doses in Primary Series Interval to First Booster (mRNA preferred) Interval to Second Booster
(mRNA preferred)
Age 18+ living in long term care, personal care homes or other senior congregate living settings 2 4 months 4 months
Age 50+ all individuals 2 4 months 4 months
Age 50+ who received Janssen vaccine 1 2 months 4 months
Age 50+ who received AstraZeneca/COVISHIELD or mixed doses followed by mRNA (Pfizer, Moderna) doses for travel varies 4 months 4 months regardless of # of doses previously received
Age 18–49 who received AstraZeneca/COVISHIELD or mixed doses followed by mRNA (Pfizer, Moderna) doses for travel varies 4 months Currently not eligible

Age 50+ clinically vulnerable individuals including:

  1. People with severe respiratory conditions, including cystic fibrosis, severe asthma and severe chronic obstructive pulmonary disease (COPD)
  2. Diabetics
  3. People with rare diseases that significantly increase the risk of infections (such as homozygous sickle cell disease)
  4. People who had their spleen removed
  5. People with very significant developmental disabilities that increase risk (such as Down syndrome)
  6. People on dialysis or with chronic kidney disease (stage 5)
  7. People with significant neuromuscular conditions requiring respiratory support

Note vulnerable individuals age 12-49 are not currently eligible for second booster doses.

2 4 months 4 months

Age 50+ moderately to severely immune compromised individuals that includes:

Stem cell and organ transplant recipients; recipients in active treatment (chemotherapy, targeted therapies, immunotherapy) for malignant, hematologic disorders; recipients of an anti-CD20 agent (e.g. rituximab, ocrelizumab, ofatumumab).

Individuals with primary or acquired immunodeficiency states:

  • Including but not limited to poorly controlled HIV/AIDS (i.e. a current CD4 count of <200 cells/µl for adults or children)
  • Primary or acquired cellular and combined immune deficiencies

Individuals on immunosuppressive or immunomodulating therapy at the time of vaccination including:

  • Those who were receiving or had received in the previous three months targeted therapy and/or immune modulating therapy for autoimmune disease
  • Those who were receiving or had received in the previous six months immunosuppressive chemotherapy or radiotherapy for any indication

Individuals with chronic immune-mediated inflammatory disease who were receiving or had received immunosuppressive therapy prior to vaccination including: methotrexate, azathioprine

Individuals who had received high-dose steroids (equivalent to ≥40mg prednisolone per day for more than a week) for any reason in the month before vaccination.

Note moderately to severely immune compromised individuals age 12-49 are not currently eligible for second booster doses.

3 3 months 4 months

Information on receiving your COVID-19 vaccination is available.

Designated vaccines, including Novavax, and fourth doses for eligible residents of First Nations and Métis communities and the Northern Service Administration District are available by SHA appointment made by calling 1-833-SASKVAX (727-5829) only.

Note that AstraZeneca is no longer available in Saskatchewan as of April 30, 2022.  Booster doses do not need to match your previous two dose COVID-19 vaccinations. If you received two doses of AstraZeneca, it is recommended and safe to receive an mRNA vaccine booster immunization.

Top

3. Vaccinations for 5 to 11-Year-Olds (Pediatric Program)

We need your feedback to improve saskatchewan.ca. Help us improve